◄ back to all posts

ZTS: Zoetis Inc. Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 74,621.52
Enterprise Value ($M) 82,162.11
Book Value ($M) 2,185.00
Book Value / Share 4.56
Price / Book 34.65
NCAV ($M) -4,193.00
NCAV / Share -8.74
Price / NCAV -18.06

Profitability (mra)
Return on Invested Capital (ROIC) 0.17
Return on Assets (ROA) 0.17
Return on Equity (ROE) 0.80

Liquidity (mrq)
Quick Ratio 2.46
Current Ratio 3.60

Balance Sheet (mrq) ($M)
Current Assets 4,399.00
Assets 10,777.00
Liabilities 8,592.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 5,825.00
Operating Income n/a
Net Income 1,424.00
Earnings Per Share Diluted 2.93
Earnings Per Share Basic 2.96

Cash Flow Statement (mra) ($M)
Cash From Operations 1,790.00
Cash from Investing -2,259.00
Cash from Financing -2,259.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-12 13G/A Vanguard Group Inc 7.85 2.83
2020-02-06 13G/A BlackRock Inc. 8.70 13.28
2018-02-14 13G/A Price T Rowe Associates Inc /md/ 4.70 -44.42
2016-07-08 13D/A Pershing Square Capital Management, L.P. 3.80 -24.35
2015-02-12 13G/A Wellington Management Group Llp 4.93
2015-02-11 13G/A State Street Corp 4.60
2015-02-04 13D/A Sachem Head Capital Management LP 0.90
2014-02-14 13G/A SAC Capital Advisors LP 1.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-08-06 10-Q Quarterly Report – 10-Q
2020-05-06 10-Q Quarterly Report – 10-Q
2020-02-13 10-K ZTS / Zoetis Inc. 10-K – Annual Report – 10-K
2019-11-07 10-Q ZTS / Zoetis Inc. 10-Q – Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-08-14 119,538 1,780,200 6.71
2020-08-13 80,765 1,192,800 6.77
2020-08-12 105,673 1,386,500 7.62
2020-08-11 79,927 1,136,600 7.03
2020-08-10 105,517 1,393,200 7.57

(click for more detail)

Similar Companies
RDY – Dr. Reddy's Laboratories Ltd. TEVA – Teva Pharmaceutical Industries Ltd.
USNA – USANA Health Sciences, Inc.


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts

Holistic